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Introduction
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia in adults above 
75 years of age and it is linked with an increased risk of thromboembolic 
events and stroke [1].
Approximately 20.9 million men and 12.6 million women have AF worldwide in 
2010 [2]. Over one million people (1.7% of the population) in the United 
Kingdom (UK) have been diagnosed with AF[4], including over 32,000 people in 
Northern Ireland (1.7%). 
It is estimated that by 2030 there will be 14-17 million patients with AF in the 
European Union and up to 215,000 newly diagnosed cases each year [2]. 
The Arrhythmia Alliance [3] states “AF and related illness, costs the NHS over 
GB£2.2 billion each year'. Approximately 10-40% of patients with AF have at 
least one hospital admission per year [2]. These costs and rising incidence 
could place a significant burden on healthcare resources in the future. Hence, it 
is important to continue to research and develop treatment and prevention 
strategies.
Cardiac Implantable Electronic Devices (CIED), such as pacemakers,
continuously record the heartbeat. They identify paroxysmal and sustained 
AF/tachyarrhythmias in 10-15% of pacemaker patients by recording Atrial High 
Rate Episodes (AHREs) [2].
The European Society of Cardiology (ESC) Guidelines for the management of 
AF[2] recommend that further stroke risk assessments should be made if >5-6 
minutes of AHRE at >180bpm are detected on a device.
Through evolving pacemaker technology programmable atrial tachyarrhythmia 
prevention and therapy algorithms aim to reduce AF. This aim of this review is 
to explore the current evidence regarding the efficacy of these algorithms. 
Objectives
Pacemakers detect subclinical atrial fibrillation that may be a
predictor of risk of stroke. Evidence for the efficacy of algorithms for 
prevention and treatment of atrial fibrillation is controversial. The aim is 
to systematically review current evidence on the efficacy of atrial anti-
tachycardia pacing (a-ATP) and atrial prevention (APP) algorithms in the 
reduction of atrial fibrillation (AF) burden in patients with implantable 
dual chamber pacemakers. 
Atrial Anti-tachycardia Pacing (a-ATP)
Delivering a pacing stimulus to the heart between the end of the 
refractory period and the next depolarisation, 8 defined as the excitable 
gap, may capture the site of origin of an arrhythmia. This is atrial pacing 
at a high frequency, marginally faster than the atrial arrhythmia rate 
(shorter cycle length) [4].
Atrial Preference Pacing (APP) 
APP provides constant overdrive atrial pacing. It periodically
lowers the rate for a pre-set amount of search beats [22]. This is to 
analyse the underlying intrinsic rhythm and ensure that the atrial pace 
interval is shorter [4]. 
Methods
The following electronic database searches identified articles relevant to 
this review subject
Scopus (2006-2017). Keywords: atrial anti-tachycardia pacing, atrial ATP, 
pacemaker, DDD, atrial fibrillation, AF, atrial flutter, advisa, enrhythm..
Medline Ovid (1946 to 7th November 2017). Keywords: atrial anti-
tachycardia pacing, atrial therapy, atrial preference pacing.
Inclusion criteria: controlled trials investigating the efficacy of atrial anti-
tachycardia pacing and/or preventative pacing algorithms in patients with 
pacemakers.
Exclusion criteria: studies involving specific subgroup population, review 
articles, dated before 2005, duplicates, retracted articles.
Secondary searches using the reference lists of relevant articles did not 
reveal any new papers. A catalogue search was performed using the 
keywords ‘pacing’ and 'cardiac or pacing'. 
Results
Conclusions
Eight papers reviewed were of good to high methodological quality. 
Findings were mildly in favour of the efficacy of atrial prevention (APP) 
algorithms and moderately against atrial anti-tachycardia pacing (a-ATP). 
However, when programmed in combination, there is good evidence to 
demonstrate a reduction in atrial fibrillation (AF) burden. 
Further research is needed to assess the algorithms independently and to 
identify the clinical characteristics of the sub-group of patients that may 
benefit. 
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SCOPUS
n=44
MEDLINE
n=28
Hand Search
n=0
Publication date older than 2004 (n=18)
Retracted by Author (n=1)
Non English language (n=2)
Review paper format (n=13)
Not meeting inclusion criteria (n=19)
Included studies (n=8)
Controlled trials investigating the efficacy of a-ATP and/or APP 
algorithms in pacemakers for the reduction of AF were included. 
The van Tulder score was used to assess the methodological 
quality of the papers. 
